A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/519 (2006.01) A61K 31/53 (2006.01) A61K 47/12 (2006.01) A61K 47/20 (2006.01) A61K 47/34 (2006.01) A61P 1/06 (2006.01) A61P 1/18 (2006.01) A61P 9/12 (2006.01) A61P 13/12 (2006.01) A61P 27/06 (2006.01) A61P 27/16 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2594709
The invention relates to a novel pharmaceutical dosage form of PDE inhibitors for the intravenous application thereof and application thereof for the treatment of diseases.
L'invention concerne un nouvelle forme pharmaceutique d'inhibiteurs de PDE pour administration intraveineuse et son utilisation dans le traitement de maladies.
Haning Helmut
Reetz Frank
Serno Peter
Bayer Healthcare Ag
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Intravenous formulations of pde-5 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intravenous formulations of pde-5 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous formulations of pde-5 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1731763